Therefore, enhancing collagen I production can bebeneficial at late stages of tendon disease.23 Hence, we hypothesize that a promising tendon tissue-specific therapeuticstrategy could be based on silencing the expression of SMAD3 whilesimultaneously enhancing the production of collagen I. The gene discussed is SMAD3; the disease is disease of the tendon.